Barclays’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$295K Sell
13,186
-1,176
-8% -$30.7K ﹤0.01% 3505
2026
Q1
$393K Sell
14,362
-20,615
-59% -$732K ﹤0.01% 3323
2025
Q4
$1.45M Sell
34,977
-44,009
-56% -$1.79M ﹤0.01% 3166
2025
Q3
$3.65M Buy
78,986
+39,570
+100% +$2.11M ﹤0.01% 2430
2025
Q2
$2.08M Sell
39,416
-1,524
-4% -$80.5K ﹤0.01% 2814
2025
Q1
$2.28M Sell
40,940
-24,994
-38% -$1.2M ﹤0.01% 2532
2024
Q4
$2.85M Buy
65,934
+30,072
+84% +$1.34M ﹤0.01% 2625
2024
Q3
$1.84M Buy
35,862
+20,559
+134% +$1.38M ﹤0.01% 2918
2024
Q2
$968K Sell
15,303
-31,301
-67% -$1.88M ﹤0.01% 2616
2024
Q1
$3.09M Buy
46,604
+4,689
+11% +$381K ﹤0.01% 2206
2023
Q4
$4.12M Buy
41,915
+20,810
+99% +$1.81M ﹤0.01% 2281
2023
Q3
$1.69M Sell
21,105
-7,705
-27% -$604K ﹤0.01% 1996
2023
Q2
$2.33M Buy
28,810
+21,999
+323% +$2.06M ﹤0.01% 1787
2023
Q1
$828K Buy
6,811
+1,071
+19% +$145K ﹤0.01% 2880
2022
Q4
$764K Sell
5,740
-118
-2% -$14.3K ﹤0.01% 3016
2022
Q3
$654K Sell
5,858
-1,053
-15% -$135K ﹤0.01% 2523
2022
Q2
$937K Sell
6,911
-760
-10% -$114K ﹤0.01% 2416
2022
Q1
$1.28M Buy
+7,671
New +$1.46M ﹤0.01% 2208

Other funds holding CNXC

Barclays's CNXC Position: Q2 2026 in Review

Barclays reduced its Concentrix (CNXC) stake by 8.2% in Q2 2026, selling an estimated $30.7K and leaving 13,186 shares worth $295K. The position accounts for ﹤0.01% of the portfolio, ranked #3505.

Barclays first reported a position in CNXC in Q1 2022 and has held it in 18 quarters since. The position peaked at $4.12M in Q4 2023. 272 funds tracked by Wall St. Rank hold CNXC as of Q2 2026.

  • Barclays held 13,186 shares of Concentrix worth $295K as of Q2 2026.
  • Barclays sold 1,176 Concentrix shares in Q2 2026, an estimated $30.7K.
  • Concentrix made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3505 holding.
  • Barclays first reported a position in Concentrix in Q1 2022 and has held it in 18 quarters since.
  • Barclays's Concentrix position peaked at $4.12M in Q4 2023.
  • 272 funds tracked by Wall St. Rank held Concentrix as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.